Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Breast 10Thoracic 4Head & Neck 4Genitourinary 4Dermatologic 4Gynecologic 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 2573Uterine Cervical Neoplasms 1693Endometrial Neoplasms 1012Fallopian Tube Neoplasms 730Carcinoma, Ovarian Epithelial 681Breast Neoplasms 676Neoplasms 436Carcinoma, Non-Small-Cell Lung 379Colorectal Neoplasms 372Stomach Neoplasms 302Pancreatic Neoplasms 302Uterine Cervical Dysplasia 273Prostatic Neoplasms 262Lung Neoplasms 250Melanoma 247Neoplasm Metastasis 216Peritoneal Neoplasms 197Carcinoma, Renal Cell 193Sarcoma 190Head and Neck Neoplasms 189Urinary Bladder Neoplasms 187Esophageal Neoplasms 187Recurrence 185Triple Negative Breast Neoplasms 181Uterine Neoplasms 176Vulvar Neoplasms 173Squamous Cell Carcinoma of Head and Neck 168Colonic Neoplasms 162Papillomavirus Infections 153Small Cell Lung Carcinoma 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Patient Satisfaction × Gynecologic × Clear all
NCT06459271 2025-12-16

Feasibility of CALM in Patients With Ovarian Cancer

University Health Network, Toronto

Phase NA Recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms, Patient Satisfaction

NCT03168048 2017-05-30

OPTIMISE-1

Heidelberg University

Phase NA Unknown
50 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Pelvic Neoplasms, Personal Satisfaction, Thoracic Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡